<DOC>
	<DOCNO>NCT01518036</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial study dose-response relationship effect somatropin ( NorditropinÂ® ) final height girl Turner Syndrome .</brief_summary>
	<brief_title>Use Somatropin Turner Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Turner Syndrome Not previously treat growth hormone androgen Welldocumented height previous 12 month Informed consent parent ( child appropriate ) Growth hormone ( GH ) deficiency base GH stimulation test</criteria>
	<gender>Female</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>